| Patent application number | Description | Published |
|---|
| 20080227809 | Arylalkylamine Vanadium (V) Salts for the Treatment and/or Prevention of Diabetes Mellitus - This invention provides compounds and pharmaceutical compositions thereof for treating human type 1 and type 2 diabetes, particularly insulin-resistant diabetes. | 09-18-2008 |
| 20090298923 | Salicylate Conjugates Useful for Treating Metabolic Disorders - The present invention is directed to methods for treating metabolic disorders with compounds that are conjugates. The conjugates of the present invention are comprised of salicylic acid, triflusal, diflusinal, salsalate, IMD-0354, ibuprofen, diclofenac, licofelone, or HTB, and one or more antioxidants. | 12-03-2009 |
| 20100234452 | Anti-Inflammatory and Antioxidant Conjugates Useful for Treating Metabolic Disorders - The present invention is directed to methods for treating metabolic disorders with compounds that are conjugates. The conjugates of the present invention are comprised of salicylic acid, triflusal, diflusinal, salsalate, IMD-0354, ibuprofen, diclofenac, licofelone, or HTB, and one or more antioxidants. | 09-16-2010 |
| 20100239552 | Combination Therapies for Treating Metabolic Disorders - This invention is directed to pharmaceutical combinations comprising an antioxidant agent, an anti-inflammatory agent, and optionally at least one other anti-diabetic agent useful for treating metabolic disorders. This invention also encompasses pharmaceutically acceptable compositions comprising an antioxidant agent, an anti-inflammatory agent, optionally at least one other anti-diabetic agent, and at least one pharmaceutically acceptable carrier. The combinations and compositions of this invention are useful as methods for treating metabolic disorders including diabetes, particularly Type I and Type II diabetes, as well as diseases and disorders associated with diabetes, including but not limited to atherosclerosis, cardiovascular disease, inflammatory disorders, nephropathy, neuropathy, retinopathy, β-cell dysfunction, dyslipidemia, LADA, metabolic syndrome, hyperglycemia, insulin resistance, and/or chronic obstructive pulmonary disease in a mammal, particularly a diabetic mammal, and specifically a human patient. This invention is particularly directed to pharmaceutical compositions comprising an lipoic acid, one or more anti-inflammatories selected from the group consisting of diflunisal, diclofenac, dexibuprofen, dexketoprofen, naproxen, and salicylate, and optionally one or more pharmaceutically acceptable carriers. The compositions of this invention are useful as methods for treating metabolic disorders including type II diabetes, insulin resistance, beta-cell dysfunction, and hyperglycemia in a patient, particularly a diabetic patient. | 09-23-2010 |
| 20120149769 | Thiocarbonates as Anti-Inflammatory and Antioxidant Compounds Useful For Treating Metabolic Disorders - The invention is directed to thiocarbonate compounds of Formula (I)-(III) and methods of treating atherosclerosis, neuropathy, nephropathy, retinopathy, inflammatory disorders, COPD, cardiovascular diseases, metabolic disorders, type I diabetes mellitus, type II diabetes mellitus, LADA, Wolfram Syndrome 1, Wolcott-Rallison syndrome, metabolic syndrome, dyslipidemia, hyperglycemia, or insulin resistance. The compounds of the invention are also useful for protecting pancreatic beta-cells and for reducing free fatty acids, triglycerides, advanced glycated end products, ROS, lipid peroxidation, tissue and plasma TNFalpha and IL6 levels, or for delaying or preventing cardiovascular complications associated with atherosclerosis. | 06-14-2012 |
| Patent application number | Description | Published |
|---|
| 20100234660 | REGENERATION OF CATALYSTS FOR DEHYDRATING ALKANES - The invention relates to a method for dehydrating alkanes, wherein the alkane is guided in a reactor for the dehydrogenation of alkanes via a catalyst, and the process may be carried out adiabatically or non-adiabatically, and the catalyst for dehydration can be regenerated after the reaction phase by means of transferring a gas, wherein said gas is guided via the catalyst after a short rinsing phase using water vapor, and said regeneration gas consists of a gas containing oxygen and of steam, and after regeneration the catalyst is freed of the gas containing oxygen by transferring steam, wherein the duration of the transfer of a gas containing oxygen is significantly reduced as compared to common methods and represents 70% or less of the total regeneration time, and the catalyst has an increased selectivity for forming alkene by means of carrying out the regeneration at a constant activity, and the catalyst is comprised of a metal of the group of platinum metals or group VIB of the periodic table of the elements, which is applied to a carrier in form of a compound or in elementary form, which substantially consists of oxides of the elements of tin, zinc, or aluminum. | 09-16-2010 |
| 20110144400 | HIGHLY POROUS FOAM CERAMICS AS CATALYST CARRIERS FOR THE DEHYDROGENATION OF ALKANES - The invention relates to a material which is suited as a carrier for catalysts in the dehydrogenation of alkanes and in the oxidative dehydrogenation of alkanes and which is made of an oxide ceramic foam and may contain combinations of the substances aluminium oxide, calcium oxide, silicon dioxide, tin oxide, zirconium dioxide, calcium aluminate, zinc aluminate, silicon carbide, and which is impregnated with one or several suitable catalytically active materials, by which the flow resistance of the catalyst decreases to a considerable degree and the accessibility of the catalytically active material improves significantly and the thermal and mechanical stability of the material increases. The invention also relates to a process for the manufacture of the material and a process for the dehydrogenation of alkanes by using the material according to the invention. | 06-16-2011 |
| 20110301392 | VARIATION OF TIN IMPREGNATION OF A CATALYST FOR ALKANE DEHYDROGENATION - A catalyst for the dehydrogenation of alkanes or alkyl substituents of hydrocarbons, is a shaped body having at least one oxide from the elements of the main or secondary group II to IV of the periodic table or of a mixed oxide thereof serving as base material of the shaped body. The catalyst further contains an additional constituent which is an oxide of an element of the main group IV of the periodic table, added during the shaping process. A platinum compound and a compound of an element of the main group IV of the periodic table is used as a surface constituent of the catalyst. The invention further relates to the production of the catalyst and to a method for the dehydrogenation of alkanes using the catalyst. | 12-08-2011 |
